Showing papers by "Michael J. Mack published in 2005"
TL;DR: A joint position statement as discussed by the authors represents the combined efforts of four professional societies (Society of Thoracic Surgeons [STS], American Association for thoracic surgery [AATS], American College of Cardiology [ACC], and Society for Cardiovascular Angiography and Interventions [SCAI]), two government agencies (the U.S. Food and Drug Administration [FDA] and the Centers for Medicare and Medicaid Services [CMS]), and numerous industry representatives to assess the foreseeable directions of a class of emerging technologies being developed to enable the percutaneous treatment of cardiac
54 citations
TL;DR: Avoidance of CPB in patients with reduced ventricular function undergoing multivessel bypass improves early survival rates and decreases the incidence of reoperation for bleeding, blood product use, and postoperative ventilatory times.
Abstract: Background: Patients with diminished ventricular function represent an increasing percentage of candidates for coronary artery bypass grafting (CABG). We have reviewed our recent experience in CABG in patients with ejection fractions (EF)
25 citations
19 citations
TL;DR: The disruptive technology of percutaneous transluminal intervention (PCI) of coronary artery disease has progressed from the primitive and relatively ineffective use of balloon angioplasty in the late 1970s to the reproducible and largely safe interventions employing drug-eluting stents and platelet inhibitors that are available today for the treatment of a greatly increased proportion of patients with coronary arteries disease.
18 citations